PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-104.03%
Negative net income growth while CRK stands at 711.60%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.94%
Less D&A growth vs. CRK's 297.50%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-204.55%
Negative yoy deferred tax while CRK stands at 239.63%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
800.00%
SBC growth well above CRK's 52.67%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-34.38%
Both reduce yoy usage, with CRK at -283.40%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-213.11%
Both yoy AR lines negative, with CRK at -263.30%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.38%
Negative yoy usage while CRK is 159.51%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-58.82%
Both negative yoy, with CRK at -984.30%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-3.44%
Negative yoy CFO while CRK is 53.43%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-1.41%
Both yoy lines negative, with CRK at -35.96%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-85.62%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
100.00%
Purchases growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
73.24%
Less 'other investing' outflow yoy vs. CRK's 200.19%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-5.16%
We reduce yoy invests while CRK stands at 78.40%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
51.16%
Debt repayment at 50-75% of CRK's 94.27%. Martin Whitman would worry about partial lag if competitor gains advantage from lower debt burdens.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.